Michael Thomas Heffernan, Chairman, President and CEO at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 300,000 shares at $25.26 ($7.6M) on 2018-06-12, disclosed to the SEC on 2018-06-13.
Open-market sale of $7.6M COLL by Chairman, President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.28 | 96,943 | $2.5M | 32.3% |
| 2 | $25.28 | 96,943 | $2.5M | 32.3% |
| 3 | $25.26 | 53,057 | $1.3M | 17.7% |
| 4 | $25.26 | 53,057 | $1.3M | 17.7% |
| Total | $25.27 avg | 300,000 | $7.6M | 100% |
| Filing → |
| COLL | SELL | 2022-12-14 | $8.4M | — | Filing → |
| COLL | SELL | 2021-03-17 | $2.5M | — | Filing → |
| COLL | SELL | 2020-08-12 | $500K | — | Filing → |